E FOR L AIM PUBLIC COMPANY LIMITEDSET: EFORL🇹🇭 TH

Internal Control · 2024

Internal Control — Board Opinion

Summary of the Board's Opinion on Internal Control

At the Board of Directors Meeting No. 2/2025 on 25 February 2025 with 4 independent directors and 3 persons of the Audit Committee in attendance, the Board of Directors assessed the Company's internal control system consists of warehousing and inventory management system, cash controls and management and advance payment control system and examine and evaluate the procedures for using Objective and Key Results (OKRs) as indicators for evaluating performance throughout the organization, by inquiring information from the management and reviewing supporting documents from each relevant department related to the aforementioned systems, continuous follow-up and corrective actions are implemented. This includes addressing identified deficiencies based on recommendations from internal auditors.

The Company's board of directors believes that the overall internal control system of the Company is adequate and appropriate. The Company has arranged for sufficient personnel to operate the system efficiently, including transactions with persons who may have conflicts of interest and related persons adequately, accordance with the Company's policies and operating manual.

Adequacy & Appropriateness of the Internal Control System

Internal Control Framework Used

FrameworkDetail
The Committee of Sponsoring Organizations of the Treadway Commission (COSO)

The Company has an internal control system and risk management practices that are appropriate for the nature of its business operations. The Audit Committee has appointed the internal auditor to conduct an internal audit assessment of the adequacy and appropriateness of the internal control system. To ensure that the Company can operate efficiently and effectively while also complying to relevant regulations and rules, and to enable the Company and its subsidiary to manage their operations efficiently and effectively in line with the spirit of sustainable business growth, transparency, integrity, and accountability, as well as to reduce or mitigate various risks, the Company and its subsidiaries have established internal control guidelines in accordance with international standards COSO. (The Committee of Sponsoring Organizations of the Tread way Commission) which can be divided into the following 5 components:

(1) Internal Control within the Organization

The Company places great importance on good corporate governance by establishing shared values and fostering a long-standing corporate culture that reflects a commitment to integrity and ethics. An independent board of directors, separate from the management team, is responsible for overseeing and improving internal control measures. This includes setting business objectives and defining Objective and Key Results (OKRs) to assess operational efficiency in alignment with the company’s goals. The Company has established clear regulations and documented operational guidelines for all systems to serve as standard procedures. Additionally, continuous initiatives are implemented, such as employee training programs, to ensure transparency and fairness for all stakeholders. The management team has also structured reporting lines, assigned decision-making authority, and defined responsibilities appropriately to achieve organizational objectives under the board’s supervision.

(2) Risk Assessment

The Company has set up a Risk Management Subcommittee and developed a risk management system baed on the COSO Enterprise Risk Management Framework, customized to suit the Compary's business operations. This system is continually enhanced and updated to ensure effective risk management.

(3) Control Activities

The Company has clearly separated the responsibilities for each position. It regularly reviews the authority manuals and operating procedures to ensure they align with the current organizational structure and operational requirements. Additionally, the company consistently evaluates performance to ensure adherence to regulations, policies, authority manuals, and procedures. This ensures that internal controls are sufficient and effective, and that operations remain up-to-date and efficient.

(4) Information & Communication

The Company prioritizes information systems and communication by continuously promoting and supporting the development of systems to ensure information is accurate and up-to-date. Advanced and efficient information technology systems have been implemented with a strong focus on data security. This includes processes such as data collection, processing, storage, and tracking to ensure that operations and critical information for management and stakeholders are complete, accurate, and accessible in a timely manner for informed business decision-making. Moreover, the Company has established comprehensive information security policies and data usage guidelines, and has implemented electronic communication systems to effectively disseminate policies, regulations, instructions, operational manuals, and other company-wide news. This facilitates seamless internal communication, enabling the accurate and timely generation of financial reports in compliance with regulatory deadlines.

(5) Monitoring Activities

An internal auditor has been appointed to monitor and promptly communicate any internal control deficiencies to the responsible parties, including senior management and the audit committee. This process ensures the internal control system remains effective and appropriate. The Board of Directors believes the Company has a sufficient and appropriate internal control system, supported by qualified personnel to implement it effectively. This system helps ensure that the company’s operations comply with good corporate governance principles and maintain transparency. Additionally, the Company has established a monitoring system to oversee its operations and those of its subsidiaries, ensuring that assets are protected from improper or unauthorized use by directors or executives. The system also ensures that adequate controls are in place for transactions with related parties or those with potential conflicts of interest.

Internal Control Deficiencies

Number of Deficiencies

MetricCurrent YearPrevious YearTwo Years Ago
Total number of internal control system deficiencies (cases)311

Deficiency Details

Period TypeStart Period (YYYY-MM)End Period (YYYY-MM)DetailProgress StatusCorrective Action
month/year Range2022-012022-12
The operational manual lacks comprehensiveness.
Incident no longer subject to action

The company has reviewed the operational manuals for the following systems:

• Sales and Marketing System

• Accounts Receivable System

• Procurement System

• Warehouse Management System

To ensure alignment with actual operations and business characteristics (Business Cases), the manuals establish clear interdepartmental connections and information recording processes. Additionally, written procedures for each operation are defined.

month/year Range2023-012023-12
The policy and operational manual on the implementation of Objective and Key Results (OKRs) lack comprehensiveness.
Incident no longer subject to action

The company has established operational procedures related to the implementation of Objective and Key Results (OKRs), setting policies and processes to cover all key activities and align with actual operations. These procedures must be reviewed annually or whenever changes occur, and it should be specified which level of management is required to review and approve any amendments. The procedures have been presented for approval and formal endorsement by the authorized personnel in writing.

month/year Range2024-012024-12
The product improvement process is inappropriate.
Implemented

• The maximum and minimum (Max-Min) stock levels should be determined for all regularly issued finished goods. Additionally, approval should be sought from the authorized personnel.

• Relevant departments collaborate to discuss sales planning and purchasing to maintain adequate inventory and meet customer demand in a timely manner.

month/year Range2024-012024-12
Identifying the causes of inappropriate product Improvements.
Implemented

The reason must be clearly stated to enable relevant departments to utilize and analyze the information accurately and effectively.

month/year Range2024-012024-12
Lack of stringency in the product issuance process.
Implemented

• Operators should be strictly instructed to verify the completeness, item details, and quantity of products being issued to ensure accuracy against the sales order, product issuance slip, and invoice/tax invoice before signing off on each issuance.

• Standard operating procedures should be established for product preparation and issuance recording, including verifying the issuance slip before submitting it to the Data Center for invoice/tax invoice processing. Additionally, a manual control register prepared by the warehouse should be submitted to the Data Center as a reference for verification purposes.

Audit Committee & Auditor Observations

Audit Committee's Opinion Differs from the Board's

No

Auditor Has Observations on Internal Control

No

Opinion on the Head of Internal Audit

Head of Internal Audit

3160

Audit Committee's Opinion on the Head of Internal Audit

The Audit Committee was assigned JP Tip Audit Company Limited to perform the internal audit of the Company. The JP Tip Audit Company Limited has appointed Mr. Thanongsak Praditthan to be the head of the internal audit of the Company on 27 February 2023. For the qualification of Head of the internal auditor, can be found in Attachment 3

The Audit Committee considers JP Tip Audit Co., Ltd. to perform its duty with independence, integrity and professionalism in adherence to the internal audit standards. The Head of Internal Audit reports directly to the Audit Committee.

Appointment, Discharge & Transfer of the Head of Internal Audit

Requires Audit Committee Approval

Yes

Description

The approval, appointment, dismissal, or transfer of the Head of Internal Audit must be concurred by the Audit Committee.

Related Party Transactions

Has Related Party Transactions

Yes

Counterparties & Transactions

Monetary Unit

1000000

Counterparties with Potential Conflicts

NamePerson / Juristic PersonType of BusinessNature of RelationshipAs of Date (YYYY-MM-DD)
Spacemed Company LimitedJuristic PersonDistributor of medical devices and equipment.

The Company has a shareholding proportion of 100.00%

- Same director in the Company

Mr. Jackrit Lohajaroensub

2024-12-31T00:00
K&W (Thailand) Company LimitedJuristic PersonDistributor of medical devices and equipment.

- Shares are held by director’s relatives in the Company

The relative of Mr. Jackrit Lohajaroensub has a shareholding proportion of 12.76%

- Same director in subsidiary

Ms. Watcharaporn Phissasunthon

2024-12-31T00:00
Altermed Care Company LimitedJuristic PersonWholesale of pharmaceutical and medical goods

- Same directors and shareholders in subsidiary

Ms. Watcharaporn Phissasunthorn has a shareholding proportion of 28.00%

2024-12-31T00:00
Mr. Preecha NuntnarumitPerson

- Director

Mr. Preecha Nuntnarumit has a shareholding proportion of 0.620% of the Company.

2024-12-31T00:00
Mr. Jackrit LohajaroensubPerson

- Director

Mr. Jackrit Lohajaroensub has a shareholding proportion of 0.931% of the Company.

2024-12-31T00:00
Ms. Watcharaporn PhissasunthornPerson

- Director of subsidiary

2024-12-31T00:00
Mr. Sampan HunpayonPerson

- Director of subsidiary

2024-12-31T00:00
Mr. Pipat YingsereePerson

- Director and director of subsidiary

2024-12-31T00:00
Mr. Chakri LohajaroensubPerson

- Relative of director

Mr. Chakri Lohajaroensub has a shareholding proportion of 1.917% of the Company.

2024-12-31T00:00

Transactions by Counterparty

Transactions
4.09 · Necessity: The related party transactions are considered to determine the appropriate price. The price is agreed and can be compared with the prices offered to third parties. The trade conditions are normal for general commerce and no transfer of benefits between companies and subsidiaries. · Description: The Company has revenue from sales to Spacemed, by selling at cost plus margin. · As of yesteryear: 1.02 · Nature of transaction: Revenue from sales · Audit committee opinion: The Audit Committee has issued the opinion regarding the connected transaction as mentioned was under normal business practice and no benefit to a related person or a person who might have a conflict of interest. · As of year before yesteryear: 11.56 · 1.95 · Necessity: The related party transactions are considered to determine the appropriate price. The price is agreed and can be compared with the prices offered to third parties. The trade conditions are normal for general commerce and no transfer of benefits between companies and subsidiaries. · Description: The Company has revenue from services from Spacemed by providing collecting payments from trade receivables and providing product delivery services, the service rate is according to the agreed price. · As of yesteryear: 2.15 · Nature of transaction: Revenues from services · Audit committee opinion: The Audit Committee has issued the opinion regarding the connected transaction as mentioned was under normal business practice and no benefit to a related person or a person who might have a conflict of interest. · As of year before yesteryear: 2.51 · 2.87 · Necessity: The related party transactions are considered to determine the appropriate price. The price is agreed and can be compared with the prices offered to third parties. The trade conditions are normal for general commerce and no transfer of benefits between companies and subsidiaries. · Description: The Company purchases products from Spacemed at cost plus margin. · As of yesteryear: 5.26 · Nature of transaction: Purchase of goods · Audit committee opinion: The Audit Committee has issued the opinion regarding the connected transaction as mentioned was under normal business practice and no benefit to a related person or a person who might have a conflict of interest. · As of year before yesteryear: 5.09 · 0.08 · Necessity: The related party transactions are considered to determine the appropriate price. The price is agreed and can be compared with the prices offered to third parties. The trade conditions are normal for general commerce and no transfer of benefits between companies and subsidiaries. · Description: Spacemed Co., Ltd. purchased products from the Company at the cost plus margin and has not yet made the payment. · As of yesteryear: 0.89 · Nature of transaction: Trade accounts receivable · Audit committee opinion: The Audit Committee has issued the opinion regarding the connected transaction as mentioned was under normal business practice and no benefit to a related person or a person who might have a conflict of interest. · As of year before yesteryear: 6.98 · 0.05 · Necessity: The related party transactions are considered to determine the appropriate price. The price is agreed and can be compared with the prices offered to third parties. The trade conditions are normal for general commerce and no transfer of benefits between companies and subsidiaries. · Description: Spacemed Co., Ltd. has hired the Company for product delivery at the agreed price and has not yet made the payment. · As of yesteryear: 1.41 · Nature of transaction: Other receivables · Audit committee opinion: The Audit Committee has issued the opinion regarding the connected transaction as mentioned was under normal business practice and no benefit to a related person or a person who might have a conflict of interest. · As of year before yesteryear: 0.0 · 0.13 · Necessity: The related party transactions are considered to determine the appropriate price. The price is agreed and can be compared with the prices offered to third parties. The trade conditions are normal for general commerce and no transfer of benefits between companies and subsidiaries. · Description: The Company purchased products from Spacemed Co., Ltd. and has not yet made the payment. · As of yesteryear: 0.22 · Nature of transaction: Trade accounts payable · Audit committee opinion: The Audit Committee has issued the opinion regarding the connected transaction as mentioned was under normal business practice and no benefit to a related person or a person who might have a conflict of interest. · As of year before yesteryear: 0.3
0.83 · Necessity: The related party transactions are considered to determine the appropriate price. The price is agreed and can be compared with the prices offered to third parties. The trade conditions are normal for general commerce and no transfer of benefits between companies/subsidiaries and related companies. · Description: The Company and Spacemed Co., Ltd. sell products to K&W (Thailand) Co., Ltd. at the cost plus margin. · As of yesteryear: 21.46 · Nature of transaction: Revenue from sales · Audit committee opinion: The Audit Committee has issued the opinion regarding the connected transaction as mentioned was under normal business practice and no benefit to a related person or a person who might have a conflict of interest. · As of year before yesteryear: 2.04 · 2.09 · Necessity: The related party transactions are considered to determine the appropriate price. The price is agreed and can be compared with the prices offered to third parties. The trade conditions are normal for general commerce and no transfer of benefits between companies/subsidiaries and related companies. · Description: The Company and Spacemed have purchased products from K&W at the cost plus margin. · As of yesteryear: 2.25 · Nature of transaction: Purchase of goods · Audit committee opinion: The Audit Committee has issued the opinion regarding the connected transaction as mentioned was under normal business practice and no benefit to a related person or a person who might have a conflict of interest. · As of year before yesteryear: 2.35 · 1.78 · Necessity: The related party transactions are considered to determine the appropriate price. The price is agreed and can be compared with the prices offered to third parties. The trade conditions are normal for general commerce and no transfer of benefits between companies/subsidiaries and related companies. · Description: The Company and Spacemed Co., Ltd. have the cost of services from using K&W (Thailand) Co., Ltd.’s medical equipment to sell laboratory analytical reagents at the agreed price. · As of yesteryear: 2.94 · Nature of transaction: Other costs · Audit committee opinion: The Audit Committee has issued the opinion regarding the connected transaction as mentioned was under normal business practice and no benefit to a related person or a person who might have a conflict of interest. · As of year before yesteryear: 4.68 · 1.2 · Necessity: The related party transactions are considered to determine the appropriate price. The price is agreed and can be compared with the prices offered to third parties. The trade conditions are normal for general commerce and no transfer of benefits between companies/subsidiaries and related companies. · Description: The Company hired K&W (Thailand) Co., Ltd. to import and transport products etc. at the market price. · As of yesteryear: 1.75 · Nature of transaction: Other expenses · Audit committee opinion: The Audit Committee has issued the opinion regarding the connected transaction as mentioned was under normal business practice and no benefit to a related person or a person who might have a conflict of interest. · As of year before yesteryear: 2.09 · 0.29 · Necessity: The related party transactions are considered to determine the appropriate price. The price is agreed and can be compared with the prices offered to third parties. The trade conditions are normal for general commerce and no transfer of benefits between companies/subsidiaries and related companies. · Description: K&W (Thailand) Co., Ltd. purchased products from the Company and has not yet made the payment. · As of yesteryear: 0.04 · Nature of transaction: Trade accounts receivable · Audit committee opinion: The Audit Committee has issued the opinion regarding the connected transaction as mentioned was under normal business practice and no benefit to a related person or a person who might have a conflict of interest. · As of year before yesteryear: 1.99 · 25.49 · Necessity: The related party transactions are considered to determine the appropriate price. The price is agreed and can be compared with the prices offered to third parties. The trade conditions are normal for general commerce and no transfer of benefits between companies/subsidiaries and related companies. · Description: The Company and Spacemed Co., Ltd. purchased products from K&W (Thailand) Co., Ltd. and have not yet made the payment. · As of yesteryear: 30.65 · Nature of transaction: Trade accounts payable · Audit committee opinion: The Audit Committee has issued the opinion regarding the connected transaction as mentioned was under normal business practice and no benefit to a related person or a person who might have a conflict of interest. · As of year before yesteryear: 49.72 · 40.94 · Necessity: The related party transactions are considered to determine the appropriate price. The price is agreed and can be compared with the prices offered to third parties. The trade conditions are normal for general commerce and no transfer of benefits between companies/subsidiaries and related companies. · Description: The Company and Spacemed Co., Ltd. use medical equipment services, import and transportation products services from K&W (Thailand) Co., Ltd. have not yet made the payment. · As of yesteryear: 46.67 · Nature of transaction: Other payables · Audit committee opinion: The Audit Committee has issued the opinion regarding the connected transaction as mentioned was under normal business practice and no benefit to a related person or a person who might have a conflict of interest. · As of year before yesteryear: 41.88
0.0 · Necessity: The related party transactions are considered to determine the appropriate price. The price is agreed and can be compared with the prices offered to third parties. The trade conditions are normal for general commerce and no transfer of benefits between companies/subsidiaries and related companies. · Description: Altermed Care Co., Ltd. rents the Company's office building at a monthly rental rate of Baht 20,000, with the office rental agreement ending in September 2023. · As of yesteryear: 0.16 · Nature of transaction: Revenues from services · Audit committee opinion: The Audit Committee has issued the opinion regarding the connected transaction as mentioned was under normal business practice and no benefit to a related person or a person who might have a conflict of interest. · As of year before yesteryear: 0.21
1.4 · Necessity: The Company and its subsidiaries lack liquidity and do not have collateral to secure loans from financial institutions. · Description: The Company borrows money from directors at an interest rate of 5.00% - 6.00% per year. · As of yesteryear: 1.4 · Nature of transaction: Interest expenses · Audit committee opinion: The Audit Committee has reviewed the connected transactions or any transactions that may conflict with the Company's interests and concluded that such transactions were reasonable. In addition, such transactions were disclosed to the Stock Exchange of Thailand in accordance with the relevant regulations. · As of year before yesteryear: 1.17 · 27.79 · Necessity: The Company and its subsidiaries lack liquidity and do not have collateral to secure loans from financial institutions. · Description: The Company borrows money from directors at an interest rate of 5.00% - 6.00% per year. · As of yesteryear: 26.89 · Nature of transaction: Short-term loans and accrued interest expense · Audit committee opinion: The Audit Committee has reviewed the connected transactions or any transactions that may conflict with the Company's interests and concluded that such transactions were reasonable. In addition, such transactions were disclosed to the Stock Exchange of Thailand in accordance with the relevant regulations. · As of year before yesteryear: 25.87
0.91 · Necessity: The Company and its subsidiaries lack liquidity and do not have collateral to secure loans from financial institutions. · Description: The Company borrows money from directors at an interest rate of 5.00% - 6.00% per year. · As of yesteryear: 1.16 · Nature of transaction: Interest expenses · Audit committee opinion: The Audit Committee has reviewed the connected transactions or any transactions that may conflict with the Company's interests and concluded that such transactions were reasonable. In addition, such transactions were disclosed to the Stock Exchange of Thailand in accordance with the relevant regulations. · As of year before yesteryear: 0.57 · 17.36 · Necessity: The Company and its subsidiaries lack liquidity and do not have collateral to secure loans from financial institutions. · Description: The Company borrows money from directors at an interest rate of 5.00% - 6.00% per year. · As of yesteryear: 20.24 · Nature of transaction: Short-term loans and accrued interest expense · Audit committee opinion: The Audit Committee has reviewed the connected transactions or any transactions that may conflict with the Company's interests and concluded that such transactions were reasonable. In addition, such transactions were disclosed to the Stock Exchange of Thailand in accordance with the relevant regulations. · As of year before yesteryear: 27.12 · 0.0 · Necessity: Spacemed Co., Ltd. directors' remuneration has not yet made the payment. · Description: Accrued Spacemed Co., Ltd. directors' remuneration. · As of yesteryear: 0.05 · Nature of transaction: Other payables · Audit committee opinion: - · As of year before yesteryear: 0.0
0.08 · Necessity: The Company and its subsidiaries lack liquidity and do not have collateral to secure loans from financial institutions. · Description: Spacemed Co., Ltd. borrows money from directors at an interest rate of 5.00% - 6.25% per year. · As of yesteryear: 0.27 · Nature of transaction: Interest expenses · Audit committee opinion: The Audit Committee has reviewed the connected transactions or any transactions that may conflict with the Company's interests and concluded that such transactions were reasonable. In addition, such transactions were disclosed to the Stock Exchange of Thailand in accordance with the relevant regulations. · As of year before yesteryear: 0.05 · 0.0 · Necessity: The Company and its subsidiaries lack liquidity and do not have collateral to secure loans from financial institutions. · Description: Spacemed Co., Ltd. borrows money from directors at an interest rate of 5.00% - 6.25% per year. · As of yesteryear: 4.11 · Nature of transaction: Short-term loans and accrued interest expense · Audit committee opinion: The Audit Committee has reviewed the connected transactions or any transactions that may conflict with the Company's interests and concluded that such transactions were reasonable. In addition, such transactions were disclosed to the Stock Exchange of Thailand in accordance with the relevant regulations. · As of year before yesteryear: 7.05 · 0.0 · Necessity: Spacemed Co., Ltd. directors' remuneration has not yet made the payment. · Description: Accrued Spacemed Co., Ltd. directors' remuneration. · As of yesteryear: 0.04 · Nature of transaction: Other payables · Audit committee opinion: - · As of year before yesteryear: 0.0
0.0 · Necessity: Spacemed Co., Ltd. directors' remuneration has not yet made the payment. · Description: Accrued Spacemed Co., Ltd. directors' remuneration. · As of yesteryear: 0.04 · Nature of transaction: Other payables · Audit committee opinion: - · As of year before yesteryear: 0.0
0.0 · Necessity: Spacemed Co., Ltd. directors' remuneration has not yet made the payment. · Description: Accrued Spacemed Co., Ltd. directors' remuneration. · As of yesteryear: 0.04 · Nature of transaction: Other payables · Audit committee opinion: - · As of year before yesteryear: 0.0
4.24 · Necessity: The Company lack liquidity and do not have collateral to secure loans from financial institutions. · Description: The Company borrows money from relative of directors at an interest rate of MLR - 0.25% per year. · As of yesteryear: 4.1 · Nature of transaction: Interest expenses · Audit committee opinion: The Audit Committee has reviewed the connected transactions or any transactions that may conflict with the Company's interests and concluded that such transactions were reasonable. In addition, such transactions were disclosed to the Stock Exchange of Thailand in accordance with the relevant regulations. · As of year before yesteryear: 3.82 · 56.82 · Necessity: The Company lack liquidity and do not have collateral to secure loans from financial institutions. · Description: The Company borrows money from relative of directors at an interest rate of MLR - 0.25% per year. · As of yesteryear: 60.81 · Nature of transaction: Loan-term loans · Audit committee opinion: The Audit Committee has reviewed the connected transactions or any transactions that may conflict with the Company's interests and concluded that such transactions were reasonable. In addition, such transactions were disclosed to the Stock Exchange of Thailand in accordance with the relevant regulations. · As of year before yesteryear: 64.8

Policy & Future Trends

Policy, Measures & Approval Process

The Company has established that related party transactions and transactions that may have conflicts of interest with the Company and its subsidiary, directors, executives, or related parties must be approved by the Audit Committee and the Board of Directors or be approved by the shareholders' meeting, as applicable. All procedures are conducted in accordance with the laws and regulations of the Stock Exchange of Thailand

Contents